<?xml version="1.0" encoding="UTF-8" standalone="no"?><SDOCTA xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" STATUS="DEF1" xsi:noNamespaceSchemaLocation="TA.xsd"><IDENT><STRING BOLD="on">P10_TA(2025)0047</STRING></IDENT><TI><STRING BOLD="on">Re-attribution of scientific and technical tasks and improving cooperation among Union agencies in the area of chemicals</STRING></TI><HIDDEN><STRING HIDDEN="on" ITALIC="on">(A10-0020/2025 - Rapporteur: Dimitris Tsiodras)</STRING></HIDDEN><TXTLST><DECISION><TI><STRING BOLD="on">Amendments adopted by the European Parliament on 1 April 2025 on the proposal for a regulation of the European Parliament and of the Council amending Regulations (EC) No 178/2002, (EC) No 401/2009, (EU) 2017/745 and (EU) 2019/1021 of the European Parliament and of the Council as regards the re-attribution of scientific and technical tasks and improving cooperation among Union agencies in the area of chemicals (COM(2023)0783 – C9-0447/2023 – 2023/0455(COD))</STRING><FOOTNOTE><FIELD> The matter was referred back for interinstitutional negotiations to the committee responsible, pursuant to Rule 60(4), fourth subparagraph (A10-0020/2025).</FIELD></FOOTNOTE></TI><NOTE>(Ordinary legislative procedure: first reading)</NOTE><TEXT><DISPOSITIF><ACTLST><ACTION/></ACTLST></DISPOSITIF><AMDLST><HD><HEAD.OLD><STRING ITALIC="on">Text proposed by the Commission</STRING></HEAD.OLD><HEAD.NEW><STRING ITALIC="on">Amendment</STRING></HEAD.NEW></HD><AMEND><TI.AMD><STRING BOLD="on">Amendment		1</STRING></TI.AMD><STI.AMD><STRING BOLD="on">Proposal for a regulation</STRING></STI.AMD><STI.AMD><STRING BOLD="on">Recital 8</STRING></STI.AMD><OLD><P><NO.P>(8)</NO.P>Correspondingly, this Regulation aims to address the eventual divergence between scientific opinions of the European Food Safety Authority and those of other Union agencies. Regulation (EC) No 178/2002 of the European Parliament and Council already contains provisions establishing a procedure to solve divergent scientific opinions. Those resolution procedures should be reinforced, in that the European Food Safety Authority and the other dissenting agency should be bound to make their best effort to resolve the divergence on general scientific issues<STRING BOLD="on"><STRING ITALIC="on">, and</STRING></STRING> only when they are not able to resolve the divergence, should they refer to risk managers.</P></OLD><NEW><P><NO.P>(8)</NO.P>Correspondingly, this Regulation aims to address the eventual divergence between scientific opinions of the European Food Safety Authority and those of other Union agencies. Regulation (EC) No 178/2002 of the European Parliament and Council already contains provisions establishing a procedure to solve divergent scientific opinions. Those resolution procedures should be reinforced, in that the European Food Safety Authority and the other dissenting agency should be bound to make their best effort to resolve the divergence on general scientific issues<STRING BOLD="on"><STRING ITALIC="on">. Differences in assessment methodologies resulting in divergent opinions, particularly with regard to the protection of vulnerable groups, should be duly justified. In such instances, priority should be given to the most protective opinion to safeguard vulnerable groups.</STRING></STRING> Only when they are not able to resolve the divergence, should they refer to risk managers.</P></NEW></AMEND><AMEND><TI.AMD><STRING BOLD="on">Amendment		2</STRING></TI.AMD><STI.AMD><STRING BOLD="on">Proposal for a regulation</STRING></STI.AMD><STI.AMD><STRING BOLD="on">Recital 9</STRING></STI.AMD><OLD><P><NO.P>(9)</NO.P>In the more specific case of scientific divergence pertaining to the hazard identification of chemical substances, a new procedure enabling the resolution of the divergence should be established. This procedure should enable the Commission to request the European Chemicals Agency, as the Union agency most equipped with expertise and capacity in hazard assessment, as well as long-standing experience with the harmonised classification and labelling process, to develop a proposal for harmonised classification and labelling, in accordance <STRING BOLD="on"><STRING ITALIC="on">the</STRING></STRING> Regulation (EC) No 1272/2008 of the European Parliament and Council, moving closer to the ‘one substance, one assessment’ vision as regards uniformity of hazard assessments of chemicals across the Union. This possibility should be reflected in the relevant provision providing for the resolution of diverging scientific opinions laid down in Regulation (EC) No 178/2002.</P></OLD><NEW><P><NO.P>(9)</NO.P>In the more specific case of scientific divergence pertaining to the hazard identification of chemical substances, a new procedure enabling the resolution of the divergence should be established. This procedure should enable the Commission to request the European Chemicals Agency, as the Union agency most equipped with expertise and capacity in hazard assessment, as well as long-standing experience with the harmonised classification and labelling process, to develop a proposal for harmonised classification and labelling, in accordance <STRING BOLD="on"><STRING ITALIC="on">with</STRING></STRING> Regulation (EC) No 1272/2008 of the European Parliament and Council, moving closer to the ‘one substance, one assessment’ vision as regards uniformity of hazard assessments of chemicals across the Union<STRING BOLD="on"><STRING ITALIC="on">, enhancing the protection of health and the environment</STRING></STRING>. This possibility should be reflected in the relevant provision providing for the resolution of diverging scientific opinions laid down in Regulation (EC) No 178/2002.</P></NEW></AMEND><AMEND><TI.AMD><STRING BOLD="on">Amendment		3</STRING></TI.AMD><STI.AMD><STRING BOLD="on">Proposal for a regulation</STRING></STI.AMD><STI.AMD><STRING BOLD="on">Recital 14 a (new)</STRING></STI.AMD><OLD/><NEW><P><NO.P>(14a)</NO.P><STRING BOLD="on"><STRING ITALIC="on">This Regulation expands the tasks, workload and remit of the scientific committees of the European Chemicals Agency. In order to provide adequate expertise, support and thorough scientific evaluations, appropriate and stable resources, capacity and governance of the scientific committees should be ensured. In this respect, the European Commission should regularly monitor the needs of the European Chemicals Agency stemming from this Regulation, and provide the Agency with sufficient and stable resources.</STRING></STRING></P></NEW></AMEND><AMEND><TI.AMD><STRING BOLD="on">Amendment		4</STRING></TI.AMD><STI.AMD><STRING BOLD="on">Proposal for a regulation</STRING></STI.AMD><STI.AMD><STRING BOLD="on">Article 1 – paragraph 1 – point 2</STRING></STI.AMD><STI.AMD><STRING BOLD="on">Regulation (EC) No 178/2002</STRING></STI.AMD><STI.AMD><STRING BOLD="on">Article 30 – paragraph 2 – subparagraph 1</STRING></STI.AMD><OLD><P>Where the Authority identifies a potential source of divergence, it shall contact the body concerned in order to ensure that all relevant scientific or technical information is shared and in order to identify the potentially contentious scientific or technical issues.</P></OLD><NEW><P>Where the Authority identifies a potential source of divergence, it shall contact the body concerned in order to ensure that all relevant scientific or technical information is shared and in order to identify the potentially contentious scientific or technical issues. <STRING BOLD="on"><STRING ITALIC="on">Differences in assessment methodologies resulting in divergent opinions shall be duly justified, especially regarding the protection of vulnerable groups.</STRING></STRING></P></NEW></AMEND><AMEND><TI.AMD><STRING BOLD="on">Amendment		5</STRING></TI.AMD><STI.AMD><STRING BOLD="on">Proposal for a regulation</STRING></STI.AMD><STI.AMD><STRING BOLD="on">Article 1 – paragraph 1 – point 2</STRING></STI.AMD><STI.AMD><STRING BOLD="on">Regulation (EC) No 178/2002</STRING></STI.AMD><STI.AMD><STRING BOLD="on">Article 30 – paragraph 2 – subparagraph 2</STRING></STI.AMD><OLD><P>The Authority and the body concerned shall cooperate to resolve the divergence. If the Authority and the body concerned are not able to resolve the divergence, they shall draw up a joint report. The report shall clearly outline the contentious scientific issues <STRING BOLD="on"><STRING ITALIC="on">and</STRING></STRING> identify the relevant uncertainties in the data and be made publicly available.</P></OLD><NEW><P>The Authority and the body concerned shall cooperate to resolve the divergence<STRING BOLD="on"><STRING ITALIC="on">, with the aim of ensuring the highest level of protection of health and the environment. Priority shall be given to the opinion that affords the highest level of protection in order to safeguard the most vulnerable groups</STRING></STRING>. If the Authority and the body concerned are not able to resolve the divergence, they shall draw up a joint report. The report shall clearly outline the contentious scientific issues<STRING BOLD="on"><STRING ITALIC="on">,</STRING></STRING> identify the relevant uncertainties in the data and <STRING BOLD="on"><STRING ITALIC="on">the possible causes for the diverging opinions, including on methodological differences, and</STRING></STRING> be made publicly available.</P></NEW></AMEND><AMEND><TI.AMD><STRING BOLD="on">Amendment		6</STRING></TI.AMD><STI.AMD><STRING BOLD="on">Proposal for a regulation</STRING></STI.AMD><STI.AMD><STRING BOLD="on">Article 1 – paragraph 1 – point 2</STRING></STI.AMD><STI.AMD><STRING BOLD="on">Regulation (EC) No 178/2002</STRING></STI.AMD><STI.AMD><STRING BOLD="on">Article 30 – paragraph 3 a (new)</STRING></STI.AMD><OLD/><NEW><P><NO.P>3a.</NO.P><STRING BOLD="on"><STRING ITALIC="on">Where a substantive divergence over scientific issues has been identified and the body in question is a Member State body, the Authority and the national body shall be obliged to cooperate with a view to either resolving the divergence or preparing a joint document clarifying the contentious scientific issues and identifying the relevant uncertainties in the data. That document shall be made public.</STRING></STRING></P></NEW></AMEND><AMEND><TI.AMD><STRING BOLD="on">Amendment		7</STRING></TI.AMD><STI.AMD><STRING BOLD="on">Proposal for a regulation</STRING></STI.AMD><STI.AMD><STRING BOLD="on">Article 1 – paragraph 1 – point 2</STRING></STI.AMD><STI.AMD><STRING BOLD="on">Regulation (EC) No 178/2002</STRING></STI.AMD><STI.AMD><STRING BOLD="on">Article 3 – paragraph 3 b (new)</STRING></STI.AMD><OLD/><NEW><P><NO.P>3b.</NO.P><STRING BOLD="on"><STRING ITALIC="on">In cases where a divergence is identified, and the Authority requests additional information from the other Union or Member State authority, the period within which the relevant authorities are required to adopt their respective output, or the joint output referred to in paragraph 2, may be extended. After consulting the body concerned, the Authority shall lay down a period within which that information is to be provided and shall inform the Commission of the additional period needed. The Commission shall inform the business operators and the Member States concerned of the extension.</STRING></STRING></P></NEW></AMEND><AMEND><TI.AMD><STRING BOLD="on">Amendment		8</STRING></TI.AMD><STI.AMD><STRING BOLD="on">Proposal for a regulation</STRING></STI.AMD><STI.AMD><STRING BOLD="on">Article 3 – paragraph 1 – point 1</STRING></STI.AMD><STI.AMD><STRING BOLD="on">Regulation (EU) 2017/745</STRING></STI.AMD><STI.AMD><STRING BOLD="on">Annex I – Section 10.4.1 – point b</STRING></STI.AMD><OLD><P><NO.P>(b)</NO.P>substances which are <STRING BOLD="on"><STRING ITALIC="on">identified</STRING></STRING> as endocrine disruptors for human health, of Category 1, in accordance with Part 3 of Annex VI to Regulation (EC) No 1272/2008 of the European Parliament and of the Council<STRING SUPERSCRIPT="on">12</STRING> and substances having endocrine-disrupting properties for which there is scientific evidence of probable serious effects to human health and which are identified in accordance with the procedure set out in Article 59 of Regulation (EC) No 1907/2006 of the European Parliament and of the Council or substances having endocrine disrupting properties relevant to human health identified in accordance with Regulation (EU) No 528/2012.</P></OLD><NEW><P><NO.P>(b)</NO.P>substances which are <STRING BOLD="on"><STRING ITALIC="on">classified</STRING></STRING> as endocrine disruptors for human health, of Category 1, in accordance with Part 3 of Annex VI to Regulation (EC) No 1272/2008 of the European Parliament and of the Council<STRING SUPERSCRIPT="on">12</STRING> and substances having endocrine-disrupting properties for which there is scientific evidence of probable serious effects to human health and which are identified in accordance with the procedure set out in Article 59 of Regulation (EC) No 1907/2006 of the European Parliament and of the Council or substances having endocrine disrupting properties relevant to human health identified in accordance with Regulation (EU) No 528/2012.</P></NEW><OLD><P>__________________</P></OLD><NEW><P>__________________</P></NEW><OLD><P><STRING SUPERSCRIPT="on">12</STRING> Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006( OJ L 353 31.12.2008, p. 1 ).</P></OLD><NEW><P><STRING SUPERSCRIPT="on">12</STRING> Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 (OJ L 353<STRING BOLD="on"><STRING ITALIC="on">,</STRING></STRING> 31.12.2008, p. 1).</P></NEW></AMEND><AMEND><TI.AMD><STRING BOLD="on">Amendment		9</STRING></TI.AMD><STI.AMD><STRING BOLD="on">Proposal for a regulation</STRING></STI.AMD><STI.AMD><STRING BOLD="on">Article 4 – paragraph 1 – point 2</STRING></STI.AMD><STI.AMD><STRING BOLD="on">Regulation (EU) 2019/1021</STRING></STI.AMD><STI.AMD><STRING BOLD="on">Article 8 – paragraph 1a – subparagraph 1 – point a</STRING></STI.AMD><OLD><P><NO.P>(a)</NO.P><STRING BOLD="on"><STRING ITALIC="on">as appropriate,</STRING></STRING> information on human health and environmental impacts of waste consisting of, containing or contaminated with POPs, including impacts on waste management;</P></OLD><NEW><P><NO.P>(a)</NO.P>information on human health and environmental impacts of waste consisting of, containing or contaminated with POPs, including impacts on waste management;</P></NEW></AMEND><AMEND><TI.AMD><STRING BOLD="on">Amendment		10</STRING></TI.AMD><STI.AMD><STRING BOLD="on">Proposal for a regulation</STRING></STI.AMD><STI.AMD><STRING BOLD="on">Article 4 – paragraph 1 – point 2</STRING></STI.AMD><STI.AMD><STRING BOLD="on">Regulation (EU) 2019/1021</STRING></STI.AMD><STI.AMD><STRING BOLD="on">Article 8 – paragraph 1a – subparagraph 2</STRING></STI.AMD><OLD><P>The Agency shall, as soon as it receives the request referred to in <STRING BOLD="on"><STRING ITALIC="on">the first subparagraph</STRING></STRING>, point (i), publish on its website a notice that a report on a possible amendment of Annex IV or V will be prepared inviting all interested parties, including waste operators and users of recycled materials, to submit comments within 8 weeks. The Agency shall publish those comments on its website.</P></OLD><NEW><P>The Agency shall, as soon as it receives the request referred to in <STRING BOLD="on"><STRING ITALIC="on">Article 8(1)</STRING></STRING>, point (i), publish on its website a notice that a report on a possible amendment of Annex IV or V will be prepared inviting all interested parties, including waste operators and users of recycled materials, to submit comments within 8 weeks. The Agency shall publish those comments on its website.</P></NEW></AMEND><AMEND><TI.AMD><STRING BOLD="on">Amendment		11</STRING></TI.AMD><STI.AMD><STRING BOLD="on">Proposal for a regulation</STRING></STI.AMD><STI.AMD><STRING BOLD="on">Article 4 – paragraph 1 – point 2</STRING></STI.AMD><STI.AMD><STRING BOLD="on">Regulation (EU) 2019/1021</STRING></STI.AMD><STI.AMD><STRING BOLD="on">Article 8 – paragraph 1a – subparagraph 3</STRING></STI.AMD><OLD><P>At the latest 9 months following the submission of <STRING BOLD="on"><STRING ITALIC="on">that</STRING></STRING> report, the Committee for Socio-economic Analysis of the Agency, set up pursuant to Article 76(1), point (d), of Regulation (EC) No 1907/2006 shall adopt an opinion on the report and on the concentration limit values proposed therein. For the purpose of adopting an opinion on the report, Article 87 of Regulation (EC) No 1907/2006 shall apply mutatis mutandis.</P></OLD><NEW><P>At the latest 9 months following the submission of the report <STRING BOLD="on"><STRING ITALIC="on">referred to in Article 8(1), point (i)</STRING></STRING>, the Committee for Socio-economic Analysis of the Agency, set up pursuant to Article 76(1), point (d), of Regulation (EC) No 1907/2006 shall adopt an opinion on the report and on the concentration limit values proposed therein. For the purpose of adopting an opinion on the report, Article 87 of Regulation (EC) No 1907/2006 shall apply mutatis mutandis.</P></NEW></AMEND><AMEND><TI.AMD><STRING BOLD="on">Amendment		12</STRING></TI.AMD><STI.AMD><STRING BOLD="on">Proposal for a regulation</STRING></STI.AMD><STI.AMD><STRING BOLD="on">Article 4 – paragraph 1 – point 4</STRING></STI.AMD><STI.AMD><STRING BOLD="on">Regulation (EU) 2019/1021</STRING></STI.AMD><STI.AMD><STRING BOLD="on">Article 15 – paragraph 2</STRING></STI.AMD><OLD><P><NO.P>2.</NO.P>The Commission is empowered to adopt delegated acts in accordance with Article 18, to amend Annexes IV and V to adapt them to the changes to the list of substances set out in <STRING BOLD="on"><STRING ITALIC="on">the </STRING></STRING>Annexes to the Convention or the Protocol or to adapt them to scientific and technical progress.</P></OLD><NEW><P><NO.P>2.</NO.P>The Commission is empowered to adopt delegated acts in accordance with Article 18, to amend Annexes IV and V to adapt them to the changes to the list of substances set out in Annexes <STRING BOLD="on"><STRING ITALIC="on">I, II or III to Regulation (EU) 2019/1021, or the Annexes</STRING></STRING> to the Convention or the Protocol or to adapt them to scientific and technical progress.</P></NEW></AMEND><AMEND><TI.AMD><STRING BOLD="on">Amendment		13</STRING></TI.AMD><STI.AMD><STRING BOLD="on">Proposal for a regulation</STRING></STI.AMD><STI.AMD><STRING BOLD="on">Article 4 – paragraph 1 – point 4 a (new)</STRING></STI.AMD><STI.AMD><STRING BOLD="on">Regulation (EU) 2019/1021</STRING></STI.AMD><STI.AMD><STRING BOLD="on">Article 16 – paragraph 2 a (new)</STRING></STI.AMD><OLD/><NEW><P><NO.P>(4a)</NO.P><STRING BOLD="on"><STRING ITALIC="on">In Article 16, the following paragraph is added:</STRING></STRING></P></NEW><OLD/><NEW><P><STRING BOLD="on"><STRING ITALIC="on">"2a.	The Commission shall monitor the situation regarding the resources of the European Chemicals Agency and tasks, workload and remit of the scientific committees of the European Chemicals Agency and present, where necessary, a legislative proposal to reflect any needs of the European Chemicals Agency stemming from tasks introduced by this Regulation and to improve the governance of its scientific committees."</STRING></STRING></P></NEW></AMEND><AMEND><TI.AMD><STRING BOLD="on">Amendment		14</STRING></TI.AMD><STI.AMD><STRING BOLD="on">Proposal for a regulation</STRING></STI.AMD><STI.AMD><STRING BOLD="on">Article 4 – paragraph 1 – point 5 – point c</STRING></STI.AMD><STI.AMD><STRING BOLD="on">Regulation (EU) 2019/1021</STRING></STI.AMD><STI.AMD><STRING BOLD="on">Article 18 – paragraph 6</STRING></STI.AMD><OLD><P><NO.P>6.</NO.P>A delegated act adopted pursuant to Articles 4(3), 10(2) and 15 shall enter into force only if no objection has been expressed either by the European Parliament or by the Council within a period of two months of notification of that act to the European Parliament and the Council or if, before the expiry of that period, the European Parliament and the Council have both informed the Commission that they will not object..</P></OLD><NEW><P><NO.P>6.</NO.P>A delegated act adopted pursuant to Articles 4(3), 10(2) and 15 shall enter into force only if no objection has been expressed either by the European Parliament or by the Council within a period of two months of notification of that act to the European Parliament and the Council or if, before the expiry of that period, the European Parliament and the Council have both informed the Commission that they will not object. <STRING BOLD="on"><STRING ITALIC="on">That period may be extended by two months at the initiative of the European Parliament or of the Council’</STRING></STRING>.</P></NEW></AMEND><AMEND><TI.AMD><STRING BOLD="on">Amendment	15</STRING></TI.AMD><STI.AMD><STRING BOLD="on">Proposal for a regulation</STRING></STI.AMD><STI.AMD><STRING BOLD="on">Article 4 – paragraph 1 – point 5 – point c a (new)</STRING></STI.AMD><STI.AMD><STRING BOLD="on">Regulation (EU) 2019/1021</STRING></STI.AMD><STI.AMD><STRING BOLD="on">Annex IV – Table 1 – Row 5</STRING></STI.AMD><TABLE><TGROUP COLS="4"><COLSPEC COLNAME="C1" COLNUM="1" COLWIDTH="25*"/><COLSPEC COLNAME="C2" COLNUM="2" COLWIDTH="17.19*"/><COLSPEC COLNAME="C3" COLNUM="3" COLWIDTH="15.64*"/><COLSPEC COLNAME="C4" COLNUM="4" COLWIDTH="42.17*"/><TBODY><ROW><ENTRY ALIGN="CENTER" COLNAME="C1" NAMEEND="C4" NAMEST="C1"><P><STRING ITALIC="on">Present text</STRING></P></ENTRY></ROW><ROW><ENTRY ALIGN="LEFT" COLNAME="C1"><P>Alkanes C10-C13, chloro (short-chain chlorinated paraffins) (SCCPs)</P></ENTRY><ENTRY ALIGN="LEFT" COLNAME="C2"><P>85535-84-8</P></ENTRY><ENTRY ALIGN="LEFT" COLNAME="C3"><P>287-476-5</P></ENTRY><ENTRY ALIGN="LEFT" COLNAME="C4"><P>1 500 mg/kg</P><P><STRING BOLD="on"><STRING ITALIC="on">The</STRING></STRING> Commission shall review that concentration limit and shall, where appropriate, adopt a <STRING BOLD="on"><STRING ITALIC="on">legislative proposal</STRING></STRING> to lower that value <STRING BOLD="on"><STRING ITALIC="on">no later than 30 December 2027</STRING></STRING>.</P></ENTRY></ROW></TBODY></TGROUP></TABLE><TABLE><TGROUP COLS="4"><COLSPEC COLNAME="C1" COLNUM="1" COLWIDTH="25*"/><COLSPEC COLNAME="C2" COLNUM="2" COLWIDTH="17.19*"/><COLSPEC COLNAME="C3" COLNUM="3" COLWIDTH="15.64*"/><COLSPEC COLNAME="C4" COLNUM="4" COLWIDTH="42.17*"/><TBODY><ROW><ENTRY ALIGN="CENTER" COLNAME="C1" NAMEEND="C4" NAMEST="C1"><P><STRING ITALIC="on">Amendment</STRING></P></ENTRY></ROW><ROW><ENTRY ALIGN="LEFT" COLNAME="C1" NAMEEND="C4" NAMEST="C1"><P><NO.P>(ca)</NO.P><STRING BOLD="on"><STRING ITALIC="on">in Annex IV, table 1, row 5 is replaced by the following:</STRING></STRING></P></ENTRY></ROW><ROW><ENTRY ALIGN="LEFT" COLNAME="C1"><P>Alkanes C10-C13, chloro (short-chain chlorinated paraffins) (SCCPs)</P></ENTRY><ENTRY ALIGN="LEFT" COLNAME="C2"><P>85535-84-8</P></ENTRY><ENTRY ALIGN="LEFT" COLNAME="C3"><P>287-476-5</P></ENTRY><ENTRY ALIGN="LEFT" COLNAME="C4"><P>1 500 mg/kg</P><P><STRING BOLD="on"><STRING ITALIC="on">By 30 December 2027, the</STRING></STRING> Commission shall review that concentration limit and shall, where appropriate, adopt a <STRING BOLD="on"><STRING ITALIC="on">delegated act in accordance with Article 15(2)</STRING></STRING> to lower that value<STRING ITALIC="on">.</STRING></P></ENTRY></ROW></TBODY></TGROUP></TABLE></AMEND><AMEND><TI.AMD><STRING BOLD="on">Amendment	16</STRING></TI.AMD><STI.AMD><STRING BOLD="on">Proposal for a regulation</STRING></STI.AMD><STI.AMD><STRING BOLD="on">Article 4 – paragraph 1 – point 5 – point c b (new)</STRING></STI.AMD><STI.AMD><STRING BOLD="on">Regulation (EU) 2019/1021</STRING></STI.AMD><STI.AMD><STRING BOLD="on">Annex IV – Table 1 – Row 12</STRING></STI.AMD><TABLE><TGROUP COLS="4"><COLSPEC COLNAME="C1" COLNUM="1" COLWIDTH="25*"/><COLSPEC COLNAME="C2" COLNUM="2" COLWIDTH="17.19*"/><COLSPEC COLNAME="C3" COLNUM="3" COLWIDTH="15.64*"/><COLSPEC COLNAME="C4" COLNUM="4" COLWIDTH="42.17*"/><TBODY><ROW><ENTRY ALIGN="CENTER" COLNAME="C1" NAMEEND="C4" NAMEST="C1"><P><STRING ITALIC="on">Present text</STRING></P></ENTRY></ROW><ROW><ENTRY ALIGN="LEFT" COLNAME="C1"><P>Polychlorinated dibenzo-p-dioxins and dibenzofurans (PCDD/PCDF) and dioxin-like polychlorinated biphenyls (dl-PCBs)</P></ENTRY><ENTRY ALIGN="LEFT" COLNAME="C2"><P> </P></ENTRY><ENTRY ALIGN="LEFT" COLNAME="C3"><P> </P></ENTRY><ENTRY ALIGN="LEFT" COLNAME="C4"><P>5 μg/kg</P><P><STRING BOLD="on"><STRING ITALIC="on">The</STRING></STRING> Commission shall review that concentration limit and shall, where appropriate, adopt a <STRING BOLD="on"><STRING ITALIC="on">legislative proposal</STRING></STRING> to lower that value<STRING BOLD="on"><STRING ITALIC="on">, where such lowering is feasible in accordance with scientific and technical progress, no later than 30 December 2027</STRING></STRING><STRING ITALIC="on">.</STRING></P></ENTRY></ROW></TBODY></TGROUP></TABLE><TABLE><TGROUP COLS="4"><COLSPEC COLNAME="C1" COLNUM="1" COLWIDTH="25*"/><COLSPEC COLNAME="C2" COLNUM="2" COLWIDTH="17.19*"/><COLSPEC COLNAME="C3" COLNUM="3" COLWIDTH="15.64*"/><COLSPEC COLNAME="C4" COLNUM="4" COLWIDTH="42.17*"/><TBODY><ROW><ENTRY ALIGN="CENTER" COLNAME="C1" NAMEEND="C4" NAMEST="C1"><P><STRING ITALIC="on">Amendment</STRING></P></ENTRY></ROW><ROW><ENTRY ALIGN="LEFT" COLNAME="C1" NAMEEND="C4" NAMEST="C1"><P><NO.P>(cb)</NO.P><STRING BOLD="on"><STRING ITALIC="on">in Annex IV, table 1, row 12 is replaced by the following:</STRING></STRING></P></ENTRY></ROW><ROW><ENTRY ALIGN="LEFT" COLNAME="C1"><P>Polychlorinated dibenzo-p-dioxins and dibenzofurans (PCDD/PCDF) and dioxin-like polychlorinated biphenyls (dl-PCBs)</P></ENTRY><ENTRY ALIGN="LEFT" COLNAME="C2"><P> </P></ENTRY><ENTRY ALIGN="LEFT" COLNAME="C3"><P> </P></ENTRY><ENTRY ALIGN="LEFT" COLNAME="C4"><P>5 μg/kg</P><P><STRING BOLD="on"><STRING ITALIC="on">By 30 December 2027, the </STRING></STRING>Commission shall review that concentration limit and shall, where appropriate, adopt a <STRING BOLD="on"><STRING ITALIC="on">delegated act in accordance with Article 15(2)</STRING></STRING> to lower that value.</P></ENTRY></ROW></TBODY></TGROUP></TABLE></AMEND><AMEND><TI.AMD><STRING BOLD="on">Amendment	17</STRING></TI.AMD><STI.AMD><STRING BOLD="on">Proposal for a regulation</STRING></STI.AMD><STI.AMD><STRING BOLD="on">Article 4 – paragraph 1 – point 5 – point c c (new)</STRING></STI.AMD><STI.AMD><STRING BOLD="on">Regulation (EU) 2019/1021</STRING></STI.AMD><STI.AMD><STRING BOLD="on">Annex IV – Table 1 – Row 27</STRING></STI.AMD><TABLE><TGROUP COLS="4"><COLSPEC COLNAME="C1" COLNUM="1" COLWIDTH="60.12*"/><COLSPEC COLNAME="C2" COLNUM="2" COLWIDTH="11.91*"/><COLSPEC COLNAME="C3" COLNUM="3" COLWIDTH="8.21*"/><COLSPEC COLNAME="C4" COLNUM="4" COLWIDTH="19.76*"/><TBODY><ROW><ENTRY ALIGN="CENTER" COLNAME="C1" NAMEEND="C4" NAMEST="C1"><P><STRING ITALIC="on">Present text</STRING></P></ENTRY></ROW><ROW><ENTRY ALIGN="LEFT" COLNAME="C1"><P>Hexabromocyclododecane<STRING SUPERSCRIPT="on">4</STRING></P></ENTRY><ENTRY ALIGN="LEFT" COLNAME="C2"><P>25637-99-4, 3194-55-6, 134237-50-6, 134237-51-7, 134237-52-8</P></ENTRY><ENTRY ALIGN="LEFT" COLNAME="C3"><P>247-148-4</P><P>221-695-9</P></ENTRY><ENTRY ALIGN="LEFT" COLNAME="C4"><P>500 mg/kg</P><P><STRING BOLD="on"><STRING ITALIC="on">The</STRING></STRING> Commission shall review that concentration limit and shall, where appropriate, adopt a <STRING BOLD="on"><STRING ITALIC="on">legislative proposal</STRING></STRING> to lower that value to not higher than 200 mg/kg<STRING BOLD="on"><STRING ITALIC="on"> no later than 30 December 2027</STRING></STRING>.</P></ENTRY></ROW><ROW><ENTRY ALIGN="LEFT" COLNAME="C1"><P>(<STRING SUPERSCRIPT="on">4</STRING>)	‘Hexabromocyclododecane’ means hexabromocyclododecane, 1,2,5,6,9,10-hexabromocyclododecane and its main diastereoisomers: alpha-hexabromocyclododecane, beta-hexabromocyclododecane and gamma-hexabromocyclododecane.</P></ENTRY><ENTRY ALIGN="LEFT" COLNAME="C2"><P> </P></ENTRY><ENTRY ALIGN="LEFT" COLNAME="C3"><P> </P></ENTRY><ENTRY ALIGN="LEFT" COLNAME="C4"><P> </P></ENTRY></ROW></TBODY></TGROUP></TABLE><TABLE><TGROUP COLS="4"><COLSPEC COLNAME="C1" COLNUM="1" COLWIDTH="60.12*"/><COLSPEC COLNAME="C2" COLNUM="2" COLWIDTH="11.91*"/><COLSPEC COLNAME="C3" COLNUM="3" COLWIDTH="8.21*"/><COLSPEC COLNAME="C4" COLNUM="4" COLWIDTH="19.76*"/><TBODY><ROW><ENTRY ALIGN="CENTER" COLNAME="C1" NAMEEND="C4" NAMEST="C1"><P><STRING ITALIC="on">Amendment</STRING></P></ENTRY></ROW><ROW><ENTRY ALIGN="LEFT" COLNAME="C1" NAMEEND="C4" NAMEST="C1"><P><NO.P>(cc)</NO.P><STRING BOLD="on"><STRING ITALIC="on">in Annex IV, table 1, row 27 is replaced by the following:</STRING></STRING></P></ENTRY></ROW><ROW><ENTRY ALIGN="LEFT" COLNAME="C1"><P>Hexabromocyclododecane<STRING SUPERSCRIPT="on">4</STRING></P></ENTRY><ENTRY ALIGN="LEFT" COLNAME="C2"><P>25637-99-4, 3194-55-6, 134237-50-6, 134237-51-7, 134237-52-8</P></ENTRY><ENTRY ALIGN="LEFT" COLNAME="C3"><P>247-148-4</P><P>221-695-9</P></ENTRY><ENTRY ALIGN="LEFT" COLNAME="C4"><P>500 mg/kg</P><P><STRING BOLD="on"><STRING ITALIC="on">By 30 December 2027, the</STRING></STRING> Commission shall review that concentration limit and shall, where appropriate, adopt a <STRING BOLD="on"><STRING ITALIC="on">delegated act in accordance with Article 15(2)</STRING></STRING> to lower that value to not higher than 200 mg/kg.</P></ENTRY></ROW><ROW><ENTRY ALIGN="LEFT" COLNAME="C1"><P>(<STRING SUPERSCRIPT="on">4</STRING>)	 ‘Hexabromocyclododecane’ means hexabromocyclododecane, 1,2,5,6,9,10-hexabromocyclododecane and its main diastereoisomers: alpha-hexabromocyclododecane, beta-hexabromocyclododecane and gamma-hexabromocyclododecane.</P></ENTRY><ENTRY ALIGN="LEFT" COLNAME="C2"><P> </P></ENTRY><ENTRY ALIGN="LEFT" COLNAME="C3"><P> </P></ENTRY><ENTRY ALIGN="LEFT" COLNAME="C4"><P> </P></ENTRY></ROW></TBODY></TGROUP></TABLE></AMEND><AMEND><TI.AMD><STRING BOLD="on">Amendment	18</STRING></TI.AMD><STI.AMD><STRING BOLD="on">Proposal for a regulation</STRING></STI.AMD><STI.AMD><STRING BOLD="on">Article 4 – paragraph 1 – point 5 – point c d (new)</STRING></STI.AMD><STI.AMD><STRING BOLD="on">Regulation (EU) 2019/1021</STRING></STI.AMD><STI.AMD><STRING BOLD="on">Annex IV – Table 1 – Row 30</STRING></STI.AMD><TABLE><TGROUP COLS="4"><COLSPEC COLNAME="C1" COLNUM="1" COLWIDTH="25*"/><COLSPEC COLNAME="C2" COLNUM="2" COLWIDTH="17.19*"/><COLSPEC COLNAME="C3" COLNUM="3" COLWIDTH="15.64*"/><COLSPEC COLNAME="C4" COLNUM="4" COLWIDTH="42.17*"/><TBODY><ROW><ENTRY ALIGN="CENTER" COLNAME="C1" NAMEEND="C4" NAMEST="C1"><P><STRING ITALIC="on">Present text</STRING></P></ENTRY></ROW><ROW><ENTRY ALIGN="LEFT" COLNAME="C1"><P>Perfluorooctanoic acid (PFOA), its salts and PFOA-related compounds, as set out in Annex I</P></ENTRY><ENTRY ALIGN="LEFT" COLNAME="C2"><P>335-67-1 and others</P></ENTRY><ENTRY ALIGN="LEFT" COLNAME="C3"><P>206-397-9 and others</P></ENTRY><ENTRY ALIGN="LEFT" COLNAME="C4"><P>1 mg/kg</P><P>(PFOA and its salts),</P><P>40 mg/kg</P><P>(sum of PFOA-related compounds)</P><P><STRING BOLD="on"><STRING ITALIC="on">The</STRING></STRING> Commission shall review that concentration limit and shall, where appropriate, adopt a <STRING BOLD="on"><STRING ITALIC="on">legislative proposal</STRING></STRING> to lower that value<STRING BOLD="on"><STRING ITALIC="on">, where such lowering is feasible in accordance with scientific and technical progress, no later than 30 December 2027</STRING></STRING>.</P></ENTRY></ROW></TBODY></TGROUP></TABLE><TABLE><TGROUP COLS="4"><COLSPEC COLNAME="C1" COLNUM="1" COLWIDTH="25*"/><COLSPEC COLNAME="C2" COLNUM="2" COLWIDTH="17.19*"/><COLSPEC COLNAME="C3" COLNUM="3" COLWIDTH="15.64*"/><COLSPEC COLNAME="C4" COLNUM="4" COLWIDTH="42.17*"/><TBODY><ROW><ENTRY ALIGN="CENTER" COLNAME="C1" NAMEEND="C4" NAMEST="C1"><P><STRING ITALIC="on">Amendment</STRING></P></ENTRY></ROW><ROW><ENTRY ALIGN="LEFT" COLNAME="C1" NAMEEND="C4" NAMEST="C1"><P><NO.P>(cd)</NO.P><STRING BOLD="on"><STRING ITALIC="on">in Annex IV, table 1, row 30 is replaced by the following:</STRING></STRING></P></ENTRY></ROW><ROW><ENTRY ALIGN="LEFT" COLNAME="C1"><P>Perfluorooctanoic acid (PFOA), its salts and PFOA-related compounds, as set out in Annex I</P></ENTRY><ENTRY ALIGN="LEFT" COLNAME="C2"><P>335-67-1 and others</P></ENTRY><ENTRY ALIGN="LEFT" COLNAME="C3"><P>206-397-9 and others</P></ENTRY><ENTRY ALIGN="LEFT" COLNAME="C4"><P>1 mg/kg</P><P>(PFOA and its salts),</P><P>40 mg/kg</P><P>(sum of PFOA-related compounds)</P><P><STRING BOLD="on"><STRING ITALIC="on">By 30 December 2027, the </STRING></STRING>Commission shall review that concentration limit and shall, where appropriate, adopt a <STRING BOLD="on"><STRING ITALIC="on">delegated act in accordance with Article 15(2)</STRING></STRING> to lower that value.</P></ENTRY></ROW></TBODY></TGROUP></TABLE></AMEND><AMEND><TI.AMD><STRING BOLD="on">Amendment	19</STRING></TI.AMD><STI.AMD><STRING BOLD="on">Proposal for a regulation</STRING></STI.AMD><STI.AMD><STRING BOLD="on">Article 4 – paragraph 1 – point 5 – point c e (new)</STRING></STI.AMD><STI.AMD><STRING BOLD="on">Regulation (EU) 2019/1021</STRING></STI.AMD><STI.AMD><STRING BOLD="on">Annex IV – Table 1 – Row 31</STRING></STI.AMD><TABLE><TGROUP COLS="4"><COLSPEC COLNAME="C1" COLNUM="1" COLWIDTH="25*"/><COLSPEC COLNAME="C2" COLNUM="2" COLWIDTH="17.19*"/><COLSPEC COLNAME="C3" COLNUM="3" COLWIDTH="15.64*"/><COLSPEC COLNAME="C4" COLNUM="4" COLWIDTH="42.17*"/><TBODY><ROW><ENTRY ALIGN="CENTER" COLNAME="C1" NAMEEND="C4" NAMEST="C1"><P><STRING ITALIC="on">Present text</STRING></P></ENTRY></ROW><ROW><ENTRY ALIGN="LEFT" COLNAME="C1"><P>Perfluorohexane sulfonic acid (PFHxS), its salts and PFHxS-related compounds</P></ENTRY><ENTRY ALIGN="LEFT" COLNAME="C2"><P>355-46-4 and others</P></ENTRY><ENTRY ALIGN="LEFT" COLNAME="C3"><P>206-587-1 and others</P></ENTRY><ENTRY ALIGN="LEFT" COLNAME="C4"><P>1 mg/kg</P><P>(PFHxS and its salts), 40 mg/kg</P><P>(sum of PFHxS-related compounds)</P><P><STRING BOLD="on"><STRING ITALIC="on">The</STRING></STRING> Commission shall review that concentration limit and shall, where appropriate, adopt a <STRING BOLD="on"><STRING ITALIC="on">legislative proposal</STRING></STRING> to lower that value<STRING BOLD="on"><STRING ITALIC="on">, where such lowering is feasible in accordance with scientific and technical progress, no later than 30 December 2027</STRING></STRING>.</P></ENTRY></ROW></TBODY></TGROUP></TABLE><TABLE><TGROUP COLS="4"><COLSPEC COLNAME="C1" COLNUM="1" COLWIDTH="25*"/><COLSPEC COLNAME="C2" COLNUM="2" COLWIDTH="17.19*"/><COLSPEC COLNAME="C3" COLNUM="3" COLWIDTH="15.64*"/><COLSPEC COLNAME="C4" COLNUM="4" COLWIDTH="42.17*"/><TBODY><ROW><ENTRY ALIGN="CENTER" COLNAME="C1" NAMEEND="C4" NAMEST="C1"><P><STRING ITALIC="on">Amendment</STRING></P></ENTRY></ROW><ROW><ENTRY ALIGN="LEFT" COLNAME="C1" NAMEEND="C4" NAMEST="C1"><P><NO.P>(ce)</NO.P><STRING BOLD="on"><STRING ITALIC="on">in Annex IV, table 1, row 31 is replaced by the following:</STRING></STRING></P></ENTRY></ROW><ROW><ENTRY ALIGN="LEFT" COLNAME="C1"><P>Perfluorohexane sulfonic acid (PFHxS), its salts and PFHxS-related compounds</P></ENTRY><ENTRY ALIGN="LEFT" COLNAME="C2"><P>355-46-4 and others</P></ENTRY><ENTRY ALIGN="LEFT" COLNAME="C3"><P>206-587-1 and others</P></ENTRY><ENTRY ALIGN="LEFT" COLNAME="C4"><P>1 mg/kg</P><P>(PFHxS and its salts), 40 mg/kg</P><P>(sum of PFHxS-related compounds)</P><P><STRING BOLD="on"><STRING ITALIC="on">By 30 December 2027, the</STRING></STRING> Commission shall review that concentration limit and shall, where appropriate, adopt a <STRING BOLD="on"><STRING ITALIC="on">delegated act in accordance with Article 15(2)</STRING></STRING> to lower that value.</P></ENTRY></ROW></TBODY></TGROUP></TABLE></AMEND></AMDLST></TEXT></DECISION></TXTLST></SDOCTA>